These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21186921)

  • 1. Silver acetate interactions with nicotine and non-nicotine smoke components.
    Rose JE; Behm FM; Murugesan T; McClernon FJ
    Exp Clin Psychopharmacol; 2010 Dec; 18(6):462-9. PubMed ID: 21186921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a 2.5-mg silver acetate lozenge on initial and long-term smoking cessation.
    Hymowitz N; Eckholdt H
    Prev Med; 1996; 25(5):537-46. PubMed ID: 8888321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
    Becker KM; Rose JE; Albino AP
    Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precessation treatment with nicotine skin patch facilitates smoking cessation.
    Rose JE; Behm FM; Westman EC; Kukovich P
    Nicotine Tob Res; 2006 Feb; 8(1):89-101. PubMed ID: 16497603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?
    Rezaishiraz H; Hyland A; Mahoney MC; O'Connor RJ; Cummings KM
    Nicotine Tob Res; 2007 Nov; 9(11):1139-46. PubMed ID: 17978987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial.
    Bullen C; McRobbie H; Thornley S; Glover M; Lin R; Laugesen M
    Tob Control; 2010 Apr; 19(2):98-103. PubMed ID: 20378585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized crossover trial of the acceptability of snus, nicotine gum, and Zonnic therapy for smoking reduction in heavy smokers.
    Caldwell B; Burgess C; Crane J
    Nicotine Tob Res; 2010 Feb; 12(2):179-83. PubMed ID: 20064899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments.
    Rose JE; Behm FM
    Nicotine Tob Res; 2004 Jun; 6(3):523-32. PubMed ID: 15203786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silver acetate for smoking cessation.
    Lancaster T; Stead LF
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD000191. PubMed ID: 22972041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silver acetate for smoking cessation.
    Lancaster T; Stead LF
    Cochrane Database Syst Rev; 2000; (2):CD000191. PubMed ID: 10796505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine.
    Benowitz NL; Zevin S; Jacob P
    J Pharmacol Exp Ther; 1998 Dec; 287(3):958-62. PubMed ID: 9864279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
    Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family support and employment as predictors of smoking cessation success: a randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in chinese smokers.
    Sun HQ; Guo S; Chen DF; Jiang ZN; Liu Y; Di XL; Yang FD; Zhang XY; Kosten TR; Lu L
    Am J Drug Alcohol Abuse; 2009; 35(3):183-8. PubMed ID: 19462302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are nicotine replacement strategies to facilitate smoking cessation safe?
    Lavelle C; Birek C; Scott DA
    J Can Dent Assoc; 2003 Oct; 69(9):592-7. PubMed ID: 14653935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation.
    Wallström M; Nilsson F; Hirsch JM
    Addiction; 2000 Aug; 95(8):1161-71. PubMed ID: 11092064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial.
    Shiffman S; Ferguson SG; Strahs KR
    Am J Prev Med; 2009 Feb; 36(2):96-104.e1. PubMed ID: 19135903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative comparisons between a nicotine delivery device (Eclipse) and conventional cigarette smoking.
    Lee EM; Malson JL; Moolchan ET; Pickworth WB
    Nicotine Tob Res; 2004 Feb; 6(1):95-102. PubMed ID: 14982693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of the Eclipse cigarette substitute and the nicotine inhaler in smokers not interested in quitting.
    Fagerström KO; Hughes JR; Callas PW
    Nicotine Tob Res; 2002; 4 Suppl 2():S141-5. PubMed ID: 12573175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.